Publication Topic

Fergie J, Gonzales T, Suh M, Jiang X, Fryzek J, Howard A, Bloomfield A. Medically attended respiratory syncytial virus hospitalizations (RSVH) and all-cause bronchiolitis hospitalizations (BH) among children aged ≤24 months at RSV season start with higher-risk congenital heart disease (CHD) before and after the 2014 American Academy of Pediatrics (AAP) policy. Presentation to IDWeek Conference on Infectious Disease, Virtual, October 2020.

Broome CM, Cunningham JM, Mullins M, Jiang X, Bylsma LC, Fryzek JP, Rosenthal A. 2020. Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis. Res Prac Thromb Haemost 4(4):628-635; doi: 10.1002/rth2.12333. PMID: 32548562.

Sacks NC, Cyr PL, Green S, Healey B, Preib M, Wood D, Pokorney S. Prevalence of patients with paroxysmal supraventricular tachycardia (PSVT) in the United States. Poster presentation, European Society for Cardiology Congress, Paris, France, September 2019.

Fryzek J, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.

Malone D, Miller B, Dean R, Arjunji R, Jensen IS, Maru B, Dabbous O. 2019. Abstract PRO10: Use of single dose gene-replacement therapy for the treatment of spinal muscular atrophy type 1: A United States payer budget impact analysis. Value in Health 22(Sup2):S336-S337; doi: 10.1016/j.jval.2019.04.1644.

Arjunji R, Dean R, Jensen IS, Miller B, Menier M, Sproule DM, Feltner DE, Droege M, et al. 2019. Abstract PBI10: Type I spinal muscular atrophy patients treated with AVXS-101 have lower use of ventilatory support, hospitalization, and associated costs compared to those treated with nusinersen. Value in Health 22(Sup 2):S48; doi: 10.1016/j.jval.2019.04.093.

Bylsma LC, Fryzek JP, Cetin K, Callaghan F, Bezold C, Mehta B, Wasser JS. 2019. Systematic literature review of treatments used for adult immune thrombocytopenia (ITP) in the second-line setting. Am J Hematol 94(1):118-132; doi: 10.1002/ajh.25301. PMID: 30264861.

Fryzek JP, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at National Organization for Rare Disorders’ Rare Disease and Orphan Products Breakthrough Summit, Washington, DC, October 2018.

Broome C, Cunningham JM, Mullins M, Jiang X, Bylsma L, Fryzek J, Rosenthal A. Incidence of thromboembolic events is increased in a retrospective analysis of a large cold agglutinin disease (CAD) cohort. Presented at the American Society of Hematology, Atlanta, GA, December 2017.

Soff GA, Ray-Coquard I, Marfil Rivera LJ, Fryzek J, Mullins M, Bylsma LC, Park JK. Literature review of thrombopoietin receptor agonists (TPO-RA) for chemotherapy-induced thrombocytopenia (CIT). Presented at the European Society for Medical Oncology 2017 Congress, Madrid, Spain, September 2017.